Form 4 for ABBV AbbVie
Accepted 2023-03-02 00:00:00 ET · period of report 2023-02-28 · accession 0001415889-23-003852 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2023-03-02 | 2023-02-28 | ABBV | Stewart Jeffrey Ryan | EVP, COMMERCIAL Ops | F - Tax | $154.28 | -24.9K | 92.3K | -21% | -$3.84M |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock, $0.01 par value | 2023-02-28 | F | D | 24,910 | $154.28 | 92,256 | D | — | — |